111 Inc
NASDAQ:YI
111 Inc
Operating Income
111 Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
Operating Income
-¥350.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Operating Income
¥2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
Operating Income
¥1.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Operating Income
¥542.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Operating Income
¥2.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Operating Income
¥1.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's Operating Income?
Operating Income
-350.1m
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's Operating Income amounts to -350.1m CNY.
What is 111 Inc's Operating Income growth rate?
Operating Income CAGR 5Y
3%
Over the last year, the Operating Income growth was 6%. The average annual Operating Income growth rates for 111 Inc have been 10% over the past three years , 3% over the past five years .